Effects of bevantolol and atenolol on symptoms, exercise tolerance and metabolic risk factors in angina pectoris

This publication has 11 references indexed in Scilit:

• Serum fatty acids, apolipoproteins, selenium and vitamin antioxidants and the risk of death from coronary artery disease
  The American Journal of Cardiology, 1985
• Comparative effects of prazosin and atenolol on plasma lipids in hypertensive patients
  The American Journal of Medicine, 1984
• Adrenergic mechanisms in control of plasma lipid concentrations.
  BMJ, 1982
• The effect on HDL cholesterol of oxprenolol and atenolol
  Scandinavian Journal of Clinical and Laboratory Investigation, 1982
• ANTI-PLATELET ACTIVITY OF BETA-ADRENERGIC ANTAGONISTS: INHIBITION OF THROMBOXANE SYNTHESIS AND PLATELET AGGREGATION IN PATIENTS RECEIVING LONG-TERM PROPRANOLOL TREATMENT
  The Lancet, 1981
• Serum lipoprotein changes during atenolol treatment of essential hypertension
  European Journal of Clinical Pharmacology, 1981
• Long-term Effect of Sotalol on Plasma Lipids
  Clinical Science, 1979
• Metabolic consequences of atenolol and propranolol in treatment of essential hypertension.
  BMJ, 1979
• Beta-blockers and plasma triglycerides.
  BMJ, 1978
• Effect of chronic administration of propranolol on lipoprotein composition
  Metabolism, 1976